2023-LB: Reduced Mortality Risk Associated with Dexcom rtCGM Compared with SMBG among People with T2D on Any Insulin Therapy
Sign Up to like & getrecommendations! Published in 2025 at "Diabetes"
DOI: 10.2337/db25-2023-lb
Abstract: Introduction and Objective: This study compared 5-year all-cause mortality among insulin-using people with type 2 diabetes (PwT2D) using Dexcom rtCGM or SMBG. Methods: Data were from Optum’s Clinformatics® de-identified database (09/2016 to 09/2024) of US… read more here.
Keywords: smbg; mortality; insulin therapy; dexcom rtcgm ... See more keywords